Lavender oil-potent anxiolytic properties via modulating voltage dependent calcium channels.

Schuwald AM, Nöldner M, Wilmes T, Klugbauer N, Leuner K, Müller WE. Lavender oil-potent anxiolytic properties via modulating voltage dependent calcium channels. Plos One. 2013;8(4):e59998. DOI: 10.1371/journal.pone.0059998. PubMed PMID: 23637742; PubMed Central PMCID: PMC3639265.

Anosmia does not impair the anxiolytic-like effect of lavender essential oil inhalation in mice.

Chioca LR, Antunes VDC, Ferro MM, Losso EM, Andreatini R. Anosmia does not impair the anxiolytic-like effect of lavender essential oil inhalation in mice. Life Sci. 2013;92(20-21):971-5. DOI: 10.1016/j.lfs.2013.03.012. PubMed PMID: 23567808.

The serotonin-1A receptor in anxiety disorders.

Akimova E, Lanzenberger R, Kasper S. The serotonin-1A receptor in anxiety disorders. Biological Psychiatry. 2009;66(7):627-35. DOI: 10.1016/j.biopsych.2009.03.012. PubMed PMID: 19423077.

Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings.

Morgan CJA, Das RK, Joye A, Curran HV, Kamboj SK. Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings. Addict Behav. 2013;38(9):2433-6. DOI: 10.1016/j.addbeh.2013.03.011. PubMed PMID: 23685330.

Mitochondrial Mobility and Neuronal Recovery.

Kaasik A. Mitochondrial Mobility and Neuronal Recovery. N Engl J Med. 2016;375(13):1295-6. DOI: 10.1056/NEJMcibr1607955. PubMed PMID: 27682040.

Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.

Burkard WP, Bonetti EP, Da Prada M, Martin JR, Polc P, Schaffner R, et al. Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A. J Pharmacol Exp Ther. 1989;248(1):391-9. PubMed PMID: 2913284.

Innate Immunity and Asthma Risk in Amish and Hutterite Farm Children.

Stein MM, Hrusch CL, Gozdz J, Igartua C, Pivniouk V, Murray SE, et al. Innate Immunity and Asthma Risk in Amish and Hutterite Farm Children. N Engl J Med. 2016;375(5):411-21. DOI: 10.1056/NEJMoa1508749. PubMed PMID: 27518660.

The pharmacology of psilocybin.

Passie T, Seifert J, Schneider U, Emrich HM. The pharmacology of psilocybin. Addict Biology. 2002;7(4):357-64. DOI: 10.1080/1355621021000005937. PubMed PMID: 14578010.

Hallucinogens.

Nichols DE. Hallucinogens. Pharmacol Ther. 2004;101(2):131-81. DOI: 10.1016/j.pharmthera.2003.11.002. PubMed PMID: 14761703.

Defining Metastatic Cell Latency.

Pollard JW. Defining Metastatic Cell Latency. N Engl J Med. 2016;375(3):280-2. DOI: 10.1056/NEJMcibr1606716. PubMed PMID: 27468066.